These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6304553)

  • 1. Responsiveness of adenohypophysial corticotrophs to hypothalamic (SME) extract remains unchanged in rats with hypothalamic lesions inhibiting CRF release.
    Stark E; Kárteszi M; Makara GB
    Neuroendocrinology; 1983 May; 36(5):330-4. PubMed ID: 6304553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two distinct corticotrophin releasing activities of vasopressin.
    Buckingham JC
    Br J Pharmacol; 1985 Jan; 84(1):213-9. PubMed ID: 2983801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypothalamic control of ACTH secretion].
    Oliver C; Conte-Devolx B; Giraud P; Gillioz P; Lissitzky JC; Boudouresque F
    Horm Res; 1980; 13(4-5):230-41. PubMed ID: 6268511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in corticotrophin releasing factor of the stalk median eminence in rats with various cuts around the medial basal hypothalamus.
    Makara GB; Stark E; Rappay G; Kárteszi M; Palkovits M
    J Endocrinol; 1979 Nov; 83(2):165-73. PubMed ID: 316445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset of glucocorticoid responsiveness of anterior pituitary corticotrophs during development is scheduled by corticotropin-releasing factor.
    Grino M; Burgunder JM; Eskay RL; Eiden LE
    Endocrinology; 1989 Jun; 124(6):2686-92. PubMed ID: 2524376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro studies on corticotropin releasing activity of vasopressin and hypothalamic median eminence extract.
    Lutz-Bucher B; Koch B; Mialhe C
    Neuroendocrinology; 1977; 23(3):181-92. PubMed ID: 197442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress.
    Hauger RL; Millan MA; Lorang M; Harwood JP; Aguilera G
    Endocrinology; 1988 Jul; 123(1):396-405. PubMed ID: 2838259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of synthetic ovine corticotropin releasing factor and arginine vasopressin on in vitro ACTH release by the anterior pituitary of rats.
    Murakami K; Hashimoto K; Ota Z
    Neuroendocrinology; 1984 Jul; 39(1):49-53. PubMed ID: 6087183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-sleep-inducing peptide (DSIP) inhibited CRF-induced ACTH secretion from rat anterior pituitary gland in vitro.
    Okajima T; Hertting G
    Horm Metab Res; 1986 Jul; 18(7):497-9. PubMed ID: 3017833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of corticotrophin releasing factor activity within the hypothalamic-pituitary complex of rats and cattle.
    Yasuda N; Greer MA; Greer SE; Panton P
    J Endocrinol; 1977 Nov; 75(2):293-303. PubMed ID: 201710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides.
    Buckingham JC
    Neuroendocrinology; 1982; 35(2):111-6. PubMed ID: 6290921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of paraventricular lesions on stimulated ACTH release and CRF in stalk-median eminence of the rat.
    Makara GB; Stark E; Kárteszi M; Palkovits M; Rappay G
    Am J Physiol; 1981 Apr; 240(4):E441-6. PubMed ID: 6261587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site of corticotropin-releasing factor (CRF) releasing elements: effect of lesions on ACTH release and adenohypophysial blood flow.
    Porter JC
    Endocrinology; 1969 Jun; 84(6):1398-403. PubMed ID: 4305943
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone releasing activity persists in the deafferented medial-basal hypothalamus of the rat.
    Antoni FA; Makara GB; Rappay G
    J Endocrinol; 1981 Dec; 91(3):415-25. PubMed ID: 6120201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovine corticotropin-releasing factor and vasopressin: antibody-quenching studies on hypothalamic extracts of normal and Brattleboro rats.
    Linton EA; Gillies GE; Lowry PJ
    Endocrinology; 1983 Nov; 113(5):1878-83. PubMed ID: 6605243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors.
    Gaillard RC; Turnill D; Sappino P; Muller AF
    Endocrinology; 1990 Jul; 127(1):101-6. PubMed ID: 2163305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adrenocortical and gonadal steroids on the secretion in vitro of corticotrophin and its hypothalamic releasing factor.
    Buckingham JC
    J Endocrinol; 1982 Apr; 93(1):123-32. PubMed ID: 6279755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.